Clementia Pharmaceuticals Inc.

CIK 1647320 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Clementia Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Apr 29, 201915-12B0001193125-19-123823
Apr 18, 2019POS AM0001144204-19-020154
Apr 18, 20196-K0001144204-19-020153
Apr 18, 201925-NSE0001354457-19-000211
Apr 18, 2019S-8 POS0001144204-19-020155
Apr 18, 2019EFFECT9999999995-19-000757
Apr 11, 20196-K0001171843-19-002363
Apr 9, 20196-K0001171843-19-002303
Mar 29, 201920-F0001171843-19-002074
Mar 13, 20196-K0001176256-19-000056
Mar 13, 2019SC 13D0001072613-19-000134
Mar 6, 20196-K0001144204-19-012562
Mar 6, 2019SC 13D0001193125-19-065668
Mar 1, 2019SC 13D/A0000947871-19-000173
Feb 28, 20196-K0001176256-19-000040
Feb 26, 20196-K0001171843-19-001201
Feb 25, 20196-K0001144204-19-009711
Feb 25, 20196-K0001144204-19-009863
Feb 20, 20196-K0001171843-19-001028
Feb 13, 2019SC 13G0001144204-19-007222
Feb 13, 2019SC 13G/A0001072613-19-000078
Feb 12, 2019SC 13G0001274173-19-000090
Feb 12, 2019SC 13G/A0000902219-19-000040
Feb 11, 20196-K0001171843-19-000828
Nov 30, 20186-K0001171843-18-008239